Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...
Researchers at the Indraprastha Institute of Information Technology (IIIT), Delhi, have developed advanced artificial ...
Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths in Europe and the U.S.—yet when detected early, the 5-year survival rate jumps to 91%. While colonoscopy remains the gold ...
Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. It should be noted that the Galleri test not currently ...
For years, it has been one of the most tantalizing ideas in medicine: One day, a simple blood test will detect nascent cancers — allowing doctors to intervene when tumors may be easier to treat. A ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
Please provide your email address to receive an email when new articles are posted on . The study will evaluate whether two multicancer early detection tests improve early detection of 10 solid tumors ...
More than 67,000 Americans are expected to be diagnosed with pancreatic cancer this year, but a new blood test is offering ...
A new technology developed at ETH Zurich is transforming a long-overlooked source of medical data — menstrual blood — into a powerful health-monitoring tool. Dubbed MenstruAI, this innovative system ...
A UK research team has developed a pioneering blood test that could change the way lung cancer is detected and monitored. The research team—which brings together academics from University Hospitals of ...